Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3033% below fair value
$28.87+0.27 (+0.94%)
Close on Nov 12, 2026Market cap $1.23BP/E 13.1Yield –
Amphastar Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Amphastar Pharmaceuticals's total assets was $1.71B at Sep 30, 2026. For fiscal 2025 it was $1.63B, up 3.3% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is $1.63B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.63B | +3.3% |
| FY2024 | Dec 31, 2024 | $1.58B | +4.3% |
| FY2023 | Dec 31, 2023 | $1.51B | +103.9% |
| FY2022 | Dec 31, 2022 | $741.99M | +10.5% |
| FY2021 | Dec 31, 2021 | $671.53M | +6.4% |
| FY2020 | Dec 31, 2020 | $631.24M | +7.5% |
| FY2019 | Dec 31, 2019 | $586.97M | +14.3% |
| FY2018 | Dec 31, 2018 | $513.56M | +13.9% |
| FY2017 | Dec 31, 2017 | $451.07M | +5.5% |
| FY2016 | Dec 31, 2016 | $427.74M | +9.6% |
| FY2015 | Dec 31, 2015 | $390.14M | +0.2% |
| FY2014 | Dec 31, 2014 | $389.37M | +14.9% |
| FY2013 | Dec 31, 2013 | $338.75M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.71B | +2.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.74B | +8.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.65B | +1.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.63B | +3.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.67B | +7.8% |
| Q2 FY2025 | Jun 30, 2025 | $1.62B | +8.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.63B | +3.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.58B | +4.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.55B | +0.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.49B | +8.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.57B | +103.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.51B | +103.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.54B | +112.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.38B | +90.4% |
| Q1 FY2023 | Mar 31, 2023 | $773.66M | +8.0% |
| Q4 FY2022 | Dec 31, 2022 | $741.99M | +10.5% |
| Q3 FY2022 | Sep 30, 2022 | $726.70M | +11.5% |
| Q2 FY2022 | Jun 30, 2022 | $723.72M | +8.7% |
| Q1 FY2022 | Mar 31, 2022 | $716.24M | +10.9% |
| Q4 FY2021 | Dec 31, 2021 | $671.53M | +6.4% |
| Q3 FY2021 | Sep 30, 2021 | $651.68M | +6.2% |
| Q2 FY2021 | Jun 30, 2021 | $665.75M | +10.9% |
| Q1 FY2021 | Mar 31, 2021 | $645.74M | +12.7% |
| Q4 FY2020 | Dec 31, 2020 | $631.24M | +7.5% |
| Q3 FY2020 | Sep 30, 2020 | $613.72M | +4.8% |
| Q2 FY2020 | Jun 30, 2020 | $600.06M | -0.2% |
| Q1 FY2020 | Mar 31, 2020 | $572.83M | +5.2% |
| Q4 FY2019 | Dec 31, 2019 | $586.97M | +14.3% |
| Q3 FY2019 | Sep 30, 2019 | $585.64M | +21.8% |
| Q2 FY2019 | Jun 30, 2019 | $601.30M | +33.1% |
| Q1 FY2019 | Mar 31, 2019 | $544.72M | +21.1% |
| Q4 FY2018 | Dec 31, 2018 | $513.56M | +13.9% |
| Q3 FY2018 | Sep 30, 2018 | $480.64M | +9.8% |
| Q2 FY2018 | Jun 30, 2018 | $451.65M | +1.7% |
| Q1 FY2018 | Mar 31, 2018 | $449.78M | +3.3% |
| Q4 FY2017 | Dec 31, 2017 | $451.07M | +5.5% |
| Q3 FY2017 | Sep 30, 2017 | $437.77M | – |
| Q2 FY2017 | Jun 30, 2017 | $444.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $435.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $427.74M | – |
See a number that looks wrong?